Trinity Biotech plc (NasdaqGS:TRIB) is looking for acquisitions. John Gillard, Chief Financial Officer said, "The Board of the company is committed to our corporate development and corporate finance activities as we continue to assess strategic opportunities for inorganic growth and balance sheet optimization".
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.825 USD | -2.59% | +41.25% | +31.70% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+31.70% | 27.45M | |
-2.58% | 8.11B | |
+7.73% | 5.67B | |
+29.76% | 5.62B | |
-15.77% | 3.89B | |
+12.42% | 2.68B | |
-61.85% | 2.58B | |
-5.50% | 2.26B | |
+23.09% | 2.03B | |
-9.25% | 1.82B |
- Stock Market
- Equities
- TRIB Stock
- News Trinity Biotech plc
- Trinity Biotech Seeks Acquisitions